Timothy Tyson - Net Worth and Insider Trading
Timothy Tyson Net Worth
The estimated net worth of Timothy Tyson is at least $243,489 dollars as of 2024-04-26. Timothy Tyson is the Director of Syros Pharmaceuticals Inc and owns about 24,932 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $127,153. Timothy Tyson is also the CEO and President of Bausch Health Companies Inc and owns about 13,496 shares of Bausch Health Companies Inc (BHC) stock worth over $116,336. Details can be seen in Timothy Tyson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy Tyson has not made any transactions after 2022-09-30 and currently still holds the listed stock(s).
Transaction Summary of Timothy Tyson
Timothy Tyson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy Tyson owns 3 companies in total, including Tyme Technologies Inc (TYME) , BioDelivery Sciences International Inc (BDSI) , and Syros Pharmaceuticals Inc (SYRS) .
Click here to see the complete history of Timothy Tyson’s form 4 insider trades.
Insider Ownership Summary of Timothy Tyson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TYME | Tyme Technologies Inc | 2017-07-27 | director |
| BDSI | BioDelivery Sciences International Inc | 2017-08-14 | director |
| SYRS | Syros Pharmaceuticals Inc | 2022-09-30 | director |
Timothy Tyson Latest Holdings Summary
Timothy Tyson currently owns a total of 2 stocks. Among these stocks, Timothy Tyson owns 24,932 shares of Syros Pharmaceuticals Inc (SYRS) as of September 30, 2022, with a value of $127,153 and a weighting of 52.22%. Timothy Tyson also owns 13,496 shares of Bausch Health Companies Inc (BHC) as of May 7, 2007, with a value of $116,336 and a weighting of 47.78%.
Latest Holdings of Timothy Tyson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2022-09-30 | 24,932 | 5.10 | 127,153 |
| BHC | Bausch Health Companies Inc | 2007-05-07 | 13,496 | 8.62 | 116,336 |
Holding Weightings of Timothy Tyson
Timothy Tyson Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy Tyson has made a total of 1 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Syros Pharmaceuticals Inc is the acquisition of 16,932 shares on September 30, 2022, which cost Timothy Tyson around $105,994.
According to the SEC Form 4 filings, Timothy Tyson has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the sale of 300 shares on May 7, 2007, which brought Timothy Tyson around $4,941.
Insider Trading History of Timothy Tyson
- 1
Timothy Tyson Trading Performance
GuruFocus tracks the stock performance after each of Timothy Tyson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy Tyson is -3.35%. GuruFocus also compares Timothy Tyson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy Tyson within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy Tyson's insider trading performs compared to the benchmark.
Performance of Timothy Tyson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.92 | -3.35 | -8.5 | -18.02 | 9.16 | -3.23 |
| Relative Return to S&P 500(%) | -1.32 | -6.86 | -14.32 | -28.55 | 0.6 | -9.68 |
Timothy Tyson Ownership Network
Ownership Network List of Timothy Tyson
Ownership Network Relation of Timothy Tyson
Timothy Tyson Owned Company Details
What does Tyme Technologies Inc do?
Who are the key executives at Tyme Technologies Inc?
Timothy Tyson is the director of Tyme Technologies Inc. Other key executives at Tyme Technologies Inc include director & 10 percent owner & Chief Operating Officer Michael Demurjian , director & 10 percent owner & CEO and Chief Science Officer Steve Hoffman , and Corporate Controller Barbara Galaini .
Tyme Technologies Inc (TYME) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tyme Technologies Inc (TYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tyme Technologies Inc (TYME) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tyme Technologies Inc (TYME)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyme Technologies Inc Insider Transactions
Timothy Tyson Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy Tyson. You might contact Timothy Tyson via mailing address: One Enterprise, Aliso Viejo Ca 92656.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
